Nested Randomized Trials in Large Cohorts and Biobanks: Studying the Health Effects of Lifestyle Factors

Most diseases are likely to result largely from the interplay of lifestyle and genetic factors. However, both observational studies and randomized trials have faced major limitations in trying to address the impact of lifestyle on health. As large cohorts and biobanks are being developed, we need to find novel, efficient ways to address the effects of lifestyle interventions. We propose that this could be done using multiple lifestyle factorial experimental designs that combine characteristics of randomized trials and epidemiologic studies. Randomized trials of simple lifestyle interventions can be nested within large cohorts linked to reliable registries of outcomes. Participants can choose from a long list of simple lifestyle randomization options and many interventions may be tested concurrently with factorial randomization. Participants can tailor their own personal trial choosing several items among long laundry lists of randomization options. Participants are citizen-scientists rather than passive subjects and this may be attractive in modern societies of health-conscious people. These trials can use the existing machinery of the cohort for data collection and outcome linkage at no or minimal additional cost. We discuss a number of issues on the implementation of multiple lifestyle factorial experimental designs, as compared with the usual observational studies and randomized trials. These include participation, the number of allowed randomizations per participant, compliance/adherence, power, false-negatives, false-positives, composite lifestyle effects, selection of outcomes, follow-up and monitoring, masking and allocation concealment, age of participants, confounding, and cost. The aim should be to combine carefully the strengths of both observational epidemiology and randomized research without compounding their limitations.

[1]  F. Collins,et al.  Merging and emerging cohorts: Necessary but not sufficient , 2007, Nature.

[2]  R. Krauss Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial , 2006, Current atherosclerosis reports.

[3]  J. Ioannidis,et al.  Evolution and Translation of Research Findings: From Bench to Where? , 2006, PLoS clinical trials.

[4]  K. Michels The women's health initiative--curse or blessing? , 2006, International journal of epidemiology.

[5]  J. Dimitrakov Saw palmetto for benign prostatic hyperplasia. , 2006, The New England journal of medicine.

[6]  Paolo Vineis,et al.  A road map for efficient and reliable human genome epidemiology , 2006, Nature Genetics.

[7]  Garnet L Anderson,et al.  Statistical Issues Arising in the Women's Health Initiative , 2005, Biometrics.

[8]  Lyle J Palmer,et al.  Genetic Epidemiology 4 Shaking the tree : mapping complex disease genes with linkage disequilibrium , 2022 .

[9]  Tim Sprosen,et al.  UK Biobank: from concept to reality. , 2005, Pharmacogenomics.

[10]  J. Ioannidis Why Most Published Research Findings Are False , 2005, PLoS medicine.

[11]  Jonathan AC Sterne,et al.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study , 2005, The Lancet.

[12]  J. Ioannidis Contradicted and initially stronger effects in highly cited clinical research. , 2005, JAMA.

[13]  F. Hu,et al.  Coffee consumption and risk of type 2 diabetes: a systematic review. , 2005, JAMA.

[14]  G. Davey Smith,et al.  Diet in childhood and adult cardiovascular and all cause mortality: the Boyd Orr cohort , 2005, Heart.

[15]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[16]  Michael M Lieber,et al.  Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2005, Journal of the National Cancer Institute.

[17]  J. Griffith,et al.  Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. , 2005, JAMA.

[18]  John D Potter,et al.  Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. , 2004, Preventive medicine.

[19]  D. Wendler Can we ensure that all research subjects give valid consent? , 2004, Archives of internal medicine.

[20]  Matthias Egger,et al.  The scandal of poor epidemiological research , 2004, BMJ : British Medical Journal.

[21]  James Flory,et al.  Interventions to improve research participants' understanding in informed consent for research: a systematic review. , 2004, JAMA.

[22]  V. McCormack,et al.  Issues in the reporting of epidemiological studies: a survey of recent practice , 2004, BMJ : British Medical Journal.

[23]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[24]  K. Courneya,et al.  Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. , 2004, Journal of clinical epidemiology.

[25]  Francis S. Collins,et al.  The case for a US prospective cohort study of genes and environment , 2004, Nature.

[26]  Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them? , 2004, Pharmacoepidemiology and drug safety.

[27]  M. Hernán A definition of causal effect for epidemiological research , 2004, Journal of Epidemiology and Community Health.

[28]  M. Etminan,et al.  The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  J. Chang-Claude,et al.  Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case–control studies in European countries , 2000, Cancer Causes & Control.

[30]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[31]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[32]  John P A Ioannidis,et al.  Genetic associations: false or true? , 2003, Trends in molecular medicine.

[33]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[34]  Ethan M Balk,et al.  Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. , 2002, JAMA.

[35]  J. Ioannidis,et al.  Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. , 2001, American journal of epidemiology.

[36]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[37]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[38]  C. la Vecchia,et al.  Coffee and cancer: a review of epidemiological studies, 1990-1999. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[40]  T. Peters,et al.  Childhood energy intake and adult mortality from cancer: the boyd orr cohort study , 1998, BMJ.

[41]  M. Stampfer Observational epidemiology is the preferred means of evaluating effects of behavioral and lifestyle modification. , 1997, Controlled Clinical Trials.

[42]  H. Adami A paradise for epidemiologists? , 1996, The Lancet.

[43]  G. Taubes Epidemiology faces its limits. , 1995, Science.

[44]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[45]  M A Province,et al.  The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. , 1995, JAMA.

[46]  D L DeMets,et al.  Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.

[47]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[48]  P. Skrabanek Has risk-factor epidemiology outlived its usefulness? , 1993, American journal of epidemiology.

[49]  J. Robins Addendum to “a new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect” , 1987 .

[50]  A. Kriska,et al.  A randomized exercise trial in older women: increased activity over two years and the factors associated with compliance. , 1986, Medicine and science in sports and exercise.

[51]  J. Robins A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .